ACHV as of Nov 2 · 18:24 ET
ACHVNasdaqIn Vitro & In Vivo Diagnostic Substances

Achieve Life Sciences, Inc. · Brief

Next report

3 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±10.9%▼−1.18%×0.11
quarterimplied−15%0+15%realized×
Q2 FY26±10.9%▼−1.18%×0.11
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 4

4disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding ACHVN-PORT · Aug 31 '26

Bear2

16managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
0.08%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ACHV report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±15.9% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.